Retinitis Pigmentosa

Overview


Plain-Language Overview

Retinitis Pigmentosa is a group of inherited eye disorders that affect the retina, the light-sensitive tissue at the back of the eye. It primarily causes a gradual loss of vision, starting with difficulty seeing at night and loss of peripheral vision. Over time, this can lead to tunnel vision and eventually significant visual impairment. The condition affects the photoreceptor cells, which are responsible for detecting light and sending visual signals to the brain. Because it progresses slowly, many people notice symptoms only in adolescence or adulthood. The disease impacts the ability to perform daily activities that require good vision, such as driving or reading.

Clinical Definition

Retinitis Pigmentosa is a genetically heterogeneous group of progressive retinal dystrophies characterized by the degeneration of rod and cone photoreceptors. The primary pathology involves mutations in genes such as RHO, RPGR, and USH2A that disrupt phototransduction or retinal cell maintenance, leading to photoreceptor apoptosis. Clinically, it presents with night blindness (nyctalopia), progressive peripheral visual field loss, and eventual central vision decline. Fundoscopic examination reveals bone spicule pigmentation, attenuated retinal vessels, and optic disc pallor. Electroretinography shows reduced or absent rod and cone responses, confirming photoreceptor dysfunction. The condition is a major cause of inherited blindness and has variable inheritance patterns including autosomal dominant, autosomal recessive, and X-linked forms.

Inciting Event

Locked content.

Latency Period

Locked content.

Diagnostic Delay

Locked content.

Clinical Presentation


Signs & Symptoms

Locked content.

History of Present Illness

Locked content.

Past Medical History

Locked content.

Family History

Locked content.

Physical Exam Findings

Locked content.

Diagnostic Workup


Diagnostic Criteria

Locked content.

Pathophysiology


Key Mechanisms

Locked content.

Organs

Locked content.

Tissues

Locked content.

Cells

Locked content.

Chemical Mediators

Locked content.

Treatments


Pharmacological Treatments

Locked content.

Non-pharmacological Treatments

Locked content.

Prevention


Pharmacological Prevention

Locked content.

Non-pharmacological Prevention

Locked content.

Outcome & Complications


Complications

Locked content.

Short-term Sequelae

Locked content.

Long-term Sequelae

Locked content.

Differential Diagnoses


Differentials

Locked content.

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site's content were generated or assisted by AI. All material has been reviewed by Erik Romano, MD, however, errors or omissions may still occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.